XML 77 R59.htm IDEA: XBRL DOCUMENT v3.22.4
Employee Benefit Plans- Schedule of Stock Options and SARs Transactions (Details) - Stock Options/SARs - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Stock Options and SARs Rollforward [Abstract]      
Beginning balance (in shares) 9,969 10,186 9,395
Granted (in shares) 2 1,982 1,996
Exercised (in shares) [1] (5,526) (1,130) (23)
Forfeited (in shares) (220) (1,069) (1,182)
Ending balance (in shares) 4,225 9,969 10,186
Vested or Expected to Vest (in shares) 2,462 6,197 6,343
Stock Options and SARs Rollforward [Abstract]      
Beginning balance (in USD per share) $ 84.37 $ 84.08 $ 94.53
Granted (in USD per share) 97.64 81.68 37.63
Exercised (in USD per share) [1] 89.70 63.98 69.59
Forfeited (in USD per share) 82.74 98.15 88.93
Ending balance (in USD per share) 77.49 84.37 84.08
Vested or Expected to Vest (in USD per share) $ 84.53 $ 95.33 $ 96.41
Intrinsic value of stock options/SARs exercised during the year $ 190.0 $ 27.0 $ 0.4
[1] The total intrinsic value of stock options/SARs exercised during the years 2022, 2021 and 2020 was $190 million, $27 million and $0.4 million, respectively.  The intrinsic value is based upon the difference between the market price of the Common Stock on the date of exercise and the grant price of the stock options/SARs.